Everything below concerns albumin binding. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-12-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | Peptide backbone with a C18 fatty diacid side chain |
| Molecular weight | Approximately 4113 Da | Consistent with a 31-residue peptide plus linker |
| Appearance | White to off-white powder | Lyophilized solid; hygroscopic if left open |
| Solubility class | Sparingly soluble to soluble in water | Varies with pH and ionic strength |
| Typical analytical method | Reversed-phase HPLC with UV detection | Often paired with mass spectrometry for identity |
== External links == Cold War International History Project: The End of the Cold War Cold War Files: The End of the Cold War Jeffrey W. Knopf "Did Reagan Win the Cold War?" Cold War Air Museum: Aircraft from this period of the Cold War
==== Immediate impact on market ==== Tariffs were primarily absorbed by importers by compressing profit margins. Oxford Economics estimated that tariffs contributed about 0.4 percentage points to the 2025 September Consumer Price Index's annual rate of 3.0%, keeping inflation above the Federal Reserve's target. Corporate earnings were significantly affected, with global companies reporting more than $35 billion in tariff-related costs ahead of the third-quarter earnings season. In August 2026, financial markets reacted sharply to heightened geopolitical tensions after President Trump threatened to bomb Oman over the Strait of Hormuz, a move that coincided with the expiration of a 60-day ceasefire arrangement with Iran. On the first day of trading after these events, major U.S. stock indices posted broad declines: the Dow Jones Industrial Average fell 0.51 percent, the S&P 500 dropped 0.52 percent, and the Nasdaq Composite lost 0.32 percent. Within the initial half-hour of trading, roughly $200 billion in market value had been erased. At the same time, the yield on 30-year Treasury bonds climbed to 5.31 percent—its highest point since June 2007—as investors sought safer assets amid rising geopolitical uncertainty and persistent inflation concerns.
Ground birch bark, fermented in sea water, is used for seasoning the woolen, hemp or linen sails and hemp rope of traditional Norwegian boats. Birch twigs bound in a bundle, also called birch, were used for birching, a form of corporal punishment. Many Native Americans in the United States and Indigenous peoples in Canada prize the birch for its bark, which because of its light weight, flexibility, and the ease with which it can be stripped from fallen trees, is often used for the construction of strong, waterproof but lightweight canoes, bowls, and wigwams. The Hughes H-4 Hercules was made mostly of birch wood, despite its better-known moniker, "The Spruce Goose". Birch plywood was specified by the BBC as the only wood that can be used in making the cabinets of the long-lived LS3/5A loudspeaker. Birch is used as firewood because of its high calorific value per unit weight and unit volume. It burns well, without popping, even when frozen, or freshly hewn. The bark will burn very well even when wet because of the oils it contains. With care, it can be split into very thin sheets that will ignite from even the smallest of sparks. Birch wood can be used to smoke foods. Birch seeds are used as leaf litter in miniature terrain models. Birch oil is used in the manufacture of Russia leather, a water-resistant leather.
The two substrates of this enzyme are D-glyceric acid and oxidised nicotinamide adenine dinucleotide (NAD+). Its products are 2-hydroxy-3-oxopropanoate, reduced NADH, and a proton. The enzyme can alternatively use nicotinamide adenine dinucleotide phosphate as its cofactor. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is (R)-glycerate:NAD(P)+ oxidoreductase. This enzyme is also called tartronate semialdehyde reductase. This enzyme participates in glyoxylate and dicarboxylate metabolism.
Sources: en.wikipedia.org
=== Environmental guidelines === Acknowledgement of the role of red meat in land use, agricultural pollution, biodiversity loss and climate change has led to multiple guidelines that combine environmental and human health. The planetary health diet based on the EAT-Lancet commission recommends a significant reduction of red meat in favor of vegetarian proteins and more sustainable meats.
William DeGrado (born 12 September 1955) is a professor at the University of California, San Francisco, where he is the Toby Herfindal Presidential Professor of Entrepreneurship and Innovation in the Department of Pharmaceutical Chemistry. As an early pioneer of protein design, he coined the term de novo protein design. He is also active in discovery of small molecule drugs for a variety of human diseases. He is a member of the U.S. National Academy of Sciences (1999), American Academy of Arts & Sciences (1997) and National Academy of Inventors. He also is a scientific cofounder of Pliant therapeutics.
In sports where physical strength is favored, athletes have used anabolic steroids, known for their ability to increase physical strength and muscle mass. The drugs mimic the effect of testosterone and dihydrotestosterone in the body. They were developed after Eastern Bloc countries demonstrated success in weightlifting during the 1940s. At the time they were using testosterone, which carried with it negative side effects, and anabolic steroids were developed as a solution. The drugs have been used across a wide range of sports from football and basketball to weightlifting and track and field. While not as life-threatening as the drugs used in endurance sports, anabolic steroids have negative side effects, including:
Both sides agreed to build a "constructive strategic and stable relationship between China and the United States based on respect, fairness, and equality." Both sides agreed to support each other in successfully hosting the APEC Leaders' Informal Meeting and the G20 Leaders' Summit. The two heads of state expressed their intention to attend the meetings hosted by the other. The two heads of state agreed that Iran should uphold its commitment not to develop nuclear weapons and that no country or organization should impose tolls on international waterways. The two heads of state recalled that China and the United States were allies in World War II and fought side by side to win the war. The two heads of state acknowledged the positive role of the China–US trade consultation mechanism and the results of the consultations between the two trade teams, including the establishment and advancement of mechanisms such as the Council of Trade, the reaching of a $30 billion reciprocal tariff reduction arrangement, and the extension of the Kuala Lumpur trade consultation results, and instructed that these be implemented. Cooperation between Chinese and American drug enforcement agencies has yielded visible results. Recently, the two sides have worked closely together to crack multiple cases involving new psychoactive substances and precursor chemicals, arresting dozens of suspects in both countries. Both sides agreed to establish a China-US artificial intelligence dialogue to exchange views on the risks and benefits of AI. The next dialogue will be held in November this year.
For example, set to a threshold of 3 μm, all cells are counted. A re-count at a threshold of 4 μm allows calculation of the number of cells of a size between 3 and 4 μm from the total counts. Diluting the blood sample 1/80 000 in a physiological saline solution allows enumeration of the erythrocytes, as the number of leukocytes does not affect the result more than by about 1/1 000 000. For the leukocyte count, cells in the same sample are hemolyzed with saponin or cetrimide so that only the nuclei of the leukocytes are counted. For platelet count, a smaller capillary diameter is used. To identify cell morphologies and variants that the counter cannot detect, microscopy remains an essential complement to the automated cell count method.
Sources: en.wikipedia.org
It is given either as a once-weekly subcutaneous injection or as an oral tablet taken once daily. The two forms use different absorption strategies, so they are not interchangeable on a milligram-for-milligram basis.
Structural modifications, including a fatty acid side chain and non-natural amino acid substitutions, slow enzymatic breakdown and promote albumin binding. These changes support once-weekly dosing rather than twice-daily administration.
The pathways involving insulin, glucagon, gastric emptying, and appetite signaling are well described. How much each pathway contributes to weight reduction in a given person is not fully established.
It is a glucagon-like peptide-1 receptor agonist, often grouped with the incretin mimetics. Its backbone is modified from the human hormone to resist enzymatic degradation and to bind albumin. These two features distinguish it from the native peptide.